GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sawai Group Holdings Co Ltd (TSE:4887) » Definitions » Revenue per Share

Sawai Group Holdings Co (TSE:4887) Revenue per Share : 円4,468.29 (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Sawai Group Holdings Co Revenue per Share?

Sawai Group Holdings Co's revenue per share for the three months ended in Mar. 2024 was 円928.78. Sawai Group Holdings Co's revenue per share for the trailing twelve months (TTM) ended in Mar. 2024 was 円4,468.29.

Warning Sign:

Sawai Group Holdings Co Ltd revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue Per Share Growth Rate of Sawai Group Holdings Co was -11.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Sawai Group Holdings Co's Revenue per Share or its related term are showing as below:

TSE:4887's 3-Year Revenue Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 6.5
* Ranked among companies with meaningful 3-Year Revenue Growth Rate only.

Sawai Group Holdings Co Revenue per Share Historical Data

The historical data trend for Sawai Group Holdings Co's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sawai Group Holdings Co Revenue per Share Chart

Sawai Group Holdings Co Annual Data
Trend Mar22 Mar23 Mar24
Revenue per Share
4,425.93 4,564.58 4,026.55

Sawai Group Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,756.18 1,206.87 1,224.87 1,107.77 928.78

Competitive Comparison of Sawai Group Holdings Co's Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Sawai Group Holdings Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sawai Group Holdings Co's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sawai Group Holdings Co's PS Ratio distribution charts can be found below:

* The bar in red indicates where Sawai Group Holdings Co's PS Ratio falls into.



Sawai Group Holdings Co Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Sawai Group Holdings Co's Revenue Per Share for the fiscal year that ended in Mar. 2024 is calculated as

Revenue Per Share (A: Mar. 2024 )=Revenue (A: Mar. 2024 )/Shares Outstanding (Diluted Average) (A: Mar. 2024 )
=176862/43.924
=4,026.55

Sawai Group Holdings Co's Revenue Per Share for the quarter that ended in Mar. 2024 is calculated as

Revenue Per Share (Q: Mar. 2024 )=Revenue (Q: Mar. 2024 )/Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
=40806/43.935
=928.78

Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円4,468.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sawai Group Holdings Co  (TSE:4887) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Sawai Group Holdings Co Revenue per Share Related Terms

Thank you for viewing the detailed overview of Sawai Group Holdings Co's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Sawai Group Holdings Co (TSE:4887) Business Description

Traded in Other Exchanges
Address
5-2-30, Miyahara, Yodogawa-ku, Osaka, JPN, 532-0003
Sawai Group Holdings Co Ltd is engaged in providing management support or guidance to domestic and foreign companies engaged in businesses related to medical and healthcare services, such as the manufacture and sale of pharmaceutical products and medical equipment, as well as various businesses incidental or related to the same.

Sawai Group Holdings Co (TSE:4887) Headlines

No Headlines